EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access · CC BY 4.0

Patient willingness to de-escalate adjuvant therapy based on predictive biomarker results in stage IIB-IIID melanoma: A cross-sectional survey

Chiara L Blomen, Jana Kelpe, Julian Kött, Mareike Rutenkröger, Isabelle Scholl, Stefan W Schneider, Christoffer Gebhardt

European Journal of Cancer · 2026-11 · 248 · 117061

DOI: 10.1016/j.ejca.2026.117061 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift European Journal of Cancer, 2026-11. Verfasst von Chiara L Blomen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Venerology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany; Fleur Hiege Center for Skin Cancer Research,…. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Melanoma, Patient Preference, Skin Neoplasms. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German Cancer Aid.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biomarkers, TumorMelanomaPatient PreferenceSkin NeoplasmsHumansCross-Sectional StudiesFemaleMaleMiddle AgedChemotherapy, AdjuvantAgedNeoplasm StagingAdultSurveys and QuestionnairesHealth Knowledge, Attitudes, PracticeGene Expression ProfilingCirculating Tumor DNA

Stichwörter der Autor:innen

BiomarkersCirculating tumour DNAGene expression profilingLiquid biopsyMelanomaPatient preferencesPatient-reported outcomesPredictive biomarkersTreatment de-escalation

Substanzen

Biomarkers, TumorCirculating Tumor DNA

Autor:innen und Institutionen

  • Department of Dermatology and Venerology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany; Fleur Hiege Center for Skin Cancer Research, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany; Mildre…
  • Department of Dermatology and Venerology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
  • Department of Dermatology and Venerology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany; Fleur Hiege Center for Skin Cancer Research, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
  • Department of Medical Psychology, Centre for Psychosocial Medicine, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.

Förderung

  • German Cancer Aid

Zitieren

APA

Blomen, C. L., Kelpe, J., Kött, J., Rutenkröger, M., Scholl, I., Schneider, S. W., & Gebhardt, C. (2026). Patient willingness to de-escalate adjuvant therapy based on predictive biomarker results in stage IIB-IIID melanoma: A cross-sectional survey. European Journal of Cancer, 248, 117061. https://doi.org/10.1016/j.ejca.2026.117061

Vancouver

Blomen CL, Kelpe J, Kött J, Rutenkröger M, Scholl I, Schneider SW, et al. Patient willingness to de-escalate adjuvant therapy based on predictive biomarker results in stage IIB-IIID melanoma: A cross-sectional survey. European Journal of Cancer. 2026;248:117061. doi:10.1016/j.ejca.2026.117061

BibTeX
@article{Blomen2026,
  author = {Blomen, Chiara L and Kelpe, Jana and Kött, Julian and Rutenkröger, Mareike and Scholl, Isabelle and Schneider, Stefan W and Gebhardt, Christoffer},
  title = {Patient willingness to de-escalate adjuvant therapy based on predictive biomarker results in stage IIB-IIID melanoma: A cross-sectional survey},
  journal = {European Journal of Cancer},
  year = {2026},
  volume = {248},
  pages = {117061},
  doi = {10.1016/j.ejca.2026.117061}
}
Kostenlos starten →